Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs Propofol for Recovery in Breast Cancer Surgery
NCT05435911Completed
- Sponsor
- Seoul National University Hospital
- Start
- Aug 2022
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of remimazolam (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Time to eye opening at 20 minutes. Started Aug 2022; status: completed.
02
Drugs
remimazolam
Beyond the preview
Go deeper on NCT05435911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05435911.